Detalles de la búsqueda
1.
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study.
Oncologist
; 29(4): 303-310, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37995313
2.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31330065
3.
Gemcitabine and carboplatin for pretreated metastatic breast cancer: the predictive value of immunohistochemically defined subtypes.
Int J Clin Oncol
; 18(2): 343-9, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22350024
4.
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study.
Neoplasia
; 45: 100937, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37769528
5.
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study.
Front Oncol
; 13: 1177681, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441419
6.
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Front Oncol
; 13: 1152123, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37260975
7.
Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy.
BMC Cancer
; 12: 482, 2012 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23083011
8.
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series.
Cancers (Basel)
; 14(2)2022 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053467
9.
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature.
Front Oncol
; 12: 797157, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35223478
10.
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study.
Cancers (Basel)
; 14(19)2022 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230758
11.
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives.
Cancers (Basel)
; 13(2)2021 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33477469
12.
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
Ther Adv Med Oncol
; 13: 17588359211059873, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35173816
13.
A phase II study of cetuximab/irinotecan in patients with heavily pretreated metastatic colorectal cancer: predictive value of early specific toxicities.
Clin Colorectal Cancer
; 7(4): 273-9, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18650196
14.
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial.
Oncotarget
; 8(33): 54528-54536, 2017 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28903361
15.
Adjuvant chemotherapy in esophageal cancer.
Rays
; 31(1): 31-5, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16999373
16.
Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?
Tumori
; 101(5): 469-73, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26108239
17.
Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer.
Anticancer Res
; 23(2C): 1917-22, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12820479
18.
Induction therapy before surgery for non-small cell lung cancer.
Rays
; 29(4): 445-52, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15852734
19.
Epirubicin and docetaxel as first-line treatment for hormonal receptor positive metastatic breast cancer: the predictive value of luminal subtype: a retrospective cohort analysis.
J Chemother
; 25(2): 112-8, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23684359
20.
Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.
Cancer
; 109(2): 274-81, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17154161